Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Prostate Cancer Metastatic × Lutetium × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 5 Urogenital Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Prostatic Diseases 1 Prostate Cancer Metastatic 1 Pheochromocytoma 1 Paraganglioma 1 Neuroendocrine Tumors 1 Metastatic Neuroendocrine Prostate Cancer 1 Metastatic Castration-resistant Prostate Cancer (mCRPC) 1 Metastatic Castration-Resistant Prostate Cancer 1 Metastatic Castration Resistant Prostate Cancer (mCRPC) 1 Lung Neoplasms 1 Gastro-enteropancreatic neuroendocrine tumor 1 Digestive System Neoplasms 1 Breast Neoplasms 1

Interventions

Radiosurgery 3 Prednisone 2 Docetaxel 2 Androgen Antagonists 2 Abiraterone Acetate 2 fludrocortisone acetate 1 enzalutamide 1 apalutamide 1 Standard of Care 1 Radiotherapy, Image-Guided 1 Radiotherapy 1 Pluvicto 1 Lutetium-177 1 Lutetium 1 Hydrocortisone 1 Gonadotropin-Releasing Hormone 1 Dexamethasone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06320067 2025-09-26

STAMPEDE2

University College, London

Phase 3 Recruiting

Prostate Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡